{
  "experiment_id": "c76b8a3745d0bc475b41440188187f7d",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "a2c885aa2a82bb5b150f213062bbeb89",
  "model_id": "us.amazon.nova-premier-v1:0",
  "system_instructions": "### Temperature\n\n1.0",
  "temperature": 1.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-12-11T05:37:54.242763",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n### Explanation:\n\n1. **Diagnosis**: The input was \"Neurofibromatosis type 1 microdeletion syndrome.\" The closest match in the controlled terminology is \"Neurofibromatosis type 1,\" so this term was used.\n\n2. **Assay**: The input was \"clinical whole-exome sequencing.\" The controlled terminology has \"whole exome sequencing,\" which matches the method described in the input after removing the non-essential modifier \"clinical.\"\n\n3. **Tumor Type**: The input was \"Plexiform neurofibroma (morphologic abnormality).\" The controlled vocabulary includes \"Plexiform Neurofibroma\" exactly, so extraneous descriptors like \"morphologic abnormality\" were removed to match the schema term precisely. \n\nThus, the corrected metadata adheres strictly to the provided schema's controlled terminology.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2649,
            "outputTokens": 230,
            "totalTokens": 2879
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "a5f8fabd-cce1-4fb6-b460-146d2e0f6bad",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:24 GMT",
                "content-type": "application/json",
                "content-length": "1172",
                "connection": "keep-alive",
                "x-amzn-requestid": "a5f8fabd-cce1-4fb6-b460-146d2e0f6bad"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}\n```\n\n### Explanation:\n\n1. **Diagnosis**: The input was \"Neurofibromatosis type 1 microdeletion syndrome.\" The closest match in the controlled terminology is \"Neurofibromatosis type 1,\" so this term was used.\n\n2. **Assay**: The input was \"clinical whole-exome sequencing.\" The controlled terminology has \"whole exome sequencing,\" which matches the method described in the input after removing the non-essential modifier \"clinical.\"\n\n3. **Tumor Type**: The input was \"Plexiform neurofibroma (morphologic abnormality).\" The controlled vocabulary includes \"Plexiform Neurofibroma\" exactly, so extraneous descriptors like \"morphologic abnormality\" were removed to match the schema term precisely. \n\nThus, the corrected metadata adheres strictly to the provided schema's controlled terminology."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2649,
              "outputTokens": 230,
              "totalTokens": 2879
            },
            "metrics": {
              "latencyMs": 3643
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2649,
          "output_tokens": 230,
          "total_tokens": 2879
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections Explanation:**\n\n1. **Diagnosis:** \n   - The input \"Neurofibromatosis type 1 with optic pathway glioma\" contains two conditions. The schema's controlled terminology does not include combined terms, so we standardize to the primary diagnosis: \"Neurofibromatosis type 1\".\n\n2. **Assay:**\n   - \"Illumina whole exome sequencing\" is a branded method, but the schema requires a standard term. \"whole exome sequencing\" is the exact term in the schema.\n\n3. **Tumor Type:**\n   - \"malignant triton tumor\" is not explicitly listed. The closest standardized equivalent in the schema is \"Malignant Peripheral Nerve Sheath Tumor\".",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2644,
            "outputTokens": 204,
            "totalTokens": 2848
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "ac857f17-7c0b-4a9b-914e-49b64a483510",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:27 GMT",
                "content-type": "application/json",
                "content-length": "1031",
                "connection": "keep-alive",
                "x-amzn-requestid": "ac857f17-7c0b-4a9b-914e-49b64a483510"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Corrections Explanation:**\n\n1. **Diagnosis:** \n   - The input \"Neurofibromatosis type 1 with optic pathway glioma\" contains two conditions. The schema's controlled terminology does not include combined terms, so we standardize to the primary diagnosis: \"Neurofibromatosis type 1\".\n\n2. **Assay:**\n   - \"Illumina whole exome sequencing\" is a branded method, but the schema requires a standard term. \"whole exome sequencing\" is the exact term in the schema.\n\n3. **Tumor Type:**\n   - \"malignant triton tumor\" is not explicitly listed. The closest standardized equivalent in the schema is \"Malignant Peripheral Nerve Sheath Tumor\"."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2644,
              "outputTokens": 204,
              "totalTokens": 2848
            },
            "metrics": {
              "latencyMs": 3274
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2644,
          "output_tokens": 204,
          "total_tokens": 2848
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:** \n   - \"Watson Syndrome\" is not listed in the `diagnosis` enum. According to best practices and the target schema, we should replace it with \"Unknown\" since it is the closest match for unspecified or unlisted conditions.\n\n2. **Assay:**\n   - \"MGI whole genome sequencing\" isn't an exact match. The schema specifies \"whole genome sequencing\" as the controlled term, so we replace the input value with this standardized term.\n\n3. **Tumor Type:**\n   - \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" should be broadened to \"Malignant Peripheral Nerve Sheath Tumor\" to match the controlled vocabulary. The additional descriptive detail (\"with Mesenchymal Differentiation\") is omitted to adhere to the schema's enumerated values.\n\nThese changes ensure alignment with the Target Schema's requirements for controlled terminology.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2641,
            "outputTokens": 243,
            "totalTokens": 2884
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "c8f74fb5-651b-4e75-a451-73053a4d30f8",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:31 GMT",
                "content-type": "application/json",
                "content-length": "1274",
                "connection": "keep-alive",
                "x-amzn-requestid": "c8f74fb5-651b-4e75-a451-73053a4d30f8"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis:** \n   - \"Watson Syndrome\" is not listed in the `diagnosis` enum. According to best practices and the target schema, we should replace it with \"Unknown\" since it is the closest match for unspecified or unlisted conditions.\n\n2. **Assay:**\n   - \"MGI whole genome sequencing\" isn't an exact match. The schema specifies \"whole genome sequencing\" as the controlled term, so we replace the input value with this standardized term.\n\n3. **Tumor Type:**\n   - \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" should be broadened to \"Malignant Peripheral Nerve Sheath Tumor\" to match the controlled vocabulary. The additional descriptive detail (\"with Mesenchymal Differentiation\") is omitted to adhere to the schema's enumerated values.\n\nThese changes ensure alignment with the Target Schema's requirements for controlled terminology."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2641,
              "outputTokens": 243,
              "totalTokens": 2884
            },
            "metrics": {
              "latencyMs": 3820
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2641,
          "output_tokens": 243,
          "total_tokens": 2884
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input value \"neurofibromatosis, familial spinal\" does not match any of the controlled terminology values directly. \"Neurofibromatosis type 1\" is the closest standard term available in the Target Schema.\n\n2. **Assay**: \"open MRI\" is not listed in the schema. The closest standardized term in the schema for a type of MRI is \"conventional MRI\".\n\n3. **TumorType**: The value \"unknown - no information available\" does not match the controlled terminology. The closest standardized term for an unknown tumor type is \"Unknown\". \n\nThese replacements adhere to the schema requirements by utilizing the exact terminology specified.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2635,
            "outputTokens": 194,
            "totalTokens": 2829
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "82812be5-93fc-4e91-bc6e-a20367847415",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:35 GMT",
                "content-type": "application/json",
                "content-length": "1026",
                "connection": "keep-alive",
                "x-amzn-requestid": "82812be5-93fc-4e91-bc6e-a20367847415"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation:**\n\n1. **Diagnosis**: The input value \"neurofibromatosis, familial spinal\" does not match any of the controlled terminology values directly. \"Neurofibromatosis type 1\" is the closest standard term available in the Target Schema.\n\n2. **Assay**: \"open MRI\" is not listed in the schema. The closest standardized term in the schema for a type of MRI is \"conventional MRI\".\n\n3. **TumorType**: The value \"unknown - no information available\" does not match the controlled terminology. The closest standardized term for an unknown tumor type is \"Unknown\". \n\nThese replacements adhere to the schema requirements by utilizing the exact terminology specified."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2635,
              "outputTokens": 194,
              "totalTokens": 2829
            },
            "metrics": {
              "latencyMs": 3749
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2635,
          "output_tokens": 194,
          "total_tokens": 2829
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n### Explanation:\n- **Diagnosis**: \"Not Applicable\" is already an exact match in the controlled terminology, so no change is needed.\n- **Assay**: \"immunohistochemistry of skin\" is too specific. The broader, standardized term is \"immunohistochemistry\".\n- **Tumor Type**: \"Cutaneous storiform neurofibroma\" does not have an exact match. The closest standardized term available is \"Neurofibroma\". While \"Cutaneous Neurofibroma\" might seem close, it is not listed, so the more general term is used.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2639,
            "outputTokens": 167,
            "totalTokens": 2806
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "147eecd6-2ab3-491e-a70a-261d60bbcadb",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:37 GMT",
                "content-type": "application/json",
                "content-length": "851",
                "connection": "keep-alive",
                "x-amzn-requestid": "147eecd6-2ab3-491e-a70a-261d60bbcadb"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n### Explanation:\n- **Diagnosis**: \"Not Applicable\" is already an exact match in the controlled terminology, so no change is needed.\n- **Assay**: \"immunohistochemistry of skin\" is too specific. The broader, standardized term is \"immunohistochemistry\".\n- **Tumor Type**: \"Cutaneous storiform neurofibroma\" does not have an exact match. The closest standardized term available is \"Neurofibroma\". While \"Cutaneous Neurofibroma\" might seem close, it is not listed, so the more general term is used."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2639,
              "outputTokens": 167,
              "totalTokens": 2806
            },
            "metrics": {
              "latencyMs": 2292
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2639,
          "output_tokens": 167,
          "total_tokens": 2806
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n1. **Diagnosis:** The input \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" corresponds to Neurofibromatosis type 1 according to the controlled terminology.\n2. **Assay:** The input \"cell viability assay using Annexin V staining\" is narrowed down to \"cell viability assay,\" which matches one of the enumerated values in the Target Schema.\n3. **Tumor Type:** \"Pedunculated Cutaneous Neurofibroma\" is specified more generally as \"Cutaneous Neurofibroma,\" aligning with the schema's values. \n\nThis ensures compliance with the provided controlled terminology and schema requirements.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2658,
            "outputTokens": 196,
            "totalTokens": 2854
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "a3eea2d5-9095-44c2-841c-7772bf4222bf",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:40 GMT",
                "content-type": "application/json",
                "content-length": "971",
                "connection": "keep-alive",
                "x-amzn-requestid": "a3eea2d5-9095-44c2-841c-7772bf4222bf"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Explanation:**\n1. **Diagnosis:** The input \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" corresponds to Neurofibromatosis type 1 according to the controlled terminology.\n2. **Assay:** The input \"cell viability assay using Annexin V staining\" is narrowed down to \"cell viability assay,\" which matches one of the enumerated values in the Target Schema.\n3. **Tumor Type:** \"Pedunculated Cutaneous Neurofibroma\" is specified more generally as \"Cutaneous Neurofibroma,\" aligning with the schema's values. \n\nThis ensures compliance with the provided controlled terminology and schema requirements."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2658,
              "outputTokens": 196,
              "totalTokens": 2854
            },
            "metrics": {
              "latencyMs": 3146
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2658,
          "output_tokens": 196,
          "total_tokens": 2854
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Steps and Explanations:**\n\n1. **Diagnosis Field**:\n   - The input term was \"Neurofibromatosis type 1 with scoliosis\". \n   - The schema provides a controlled vocabulary where \"Neurofibromatosis type 1\" exists exactly but \"with scoliosis\" is extraneous information not included in the enum.\n   - Therefore, the standardized value is simply \"Neurofibromatosis type 1\".\n\n2. **Assay Field**:\n   - The input term was \"anti-tag immunocytochemistry\".\n   - The schema's enum for assays includes \"immunocytochemistry\" but not \"anti-tag immunocytochemistry\".\n   - \"anti-tag\" is considered a specific detail that gets generalized to the broader term \"immunocytochemistry\".\n\n3. **TumorType Field**:\n   - The input term was \"sessile cutaneous neurofibroma\".\n   - \"Sessile\" describes a specific morphology not recognized in the schema. The closest match in the enum is \"Cutaneous Neurofibroma\".\n   - Hence, it is broadened to \"Cutaneous Neurofibroma\".\n\nThe resultant metadata strictly adheres to the controlled terminology in the schema.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2645,
            "outputTokens": 314,
            "totalTokens": 2959
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "a2f434d7-3bc6-489e-b376-4f7f3bc0b623",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:45 GMT",
                "content-type": "application/json",
                "content-length": "1429",
                "connection": "keep-alive",
                "x-amzn-requestid": "a2f434d7-3bc6-489e-b376-4f7f3bc0b623"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n```\n\n**Steps and Explanations:**\n\n1. **Diagnosis Field**:\n   - The input term was \"Neurofibromatosis type 1 with scoliosis\". \n   - The schema provides a controlled vocabulary where \"Neurofibromatosis type 1\" exists exactly but \"with scoliosis\" is extraneous information not included in the enum.\n   - Therefore, the standardized value is simply \"Neurofibromatosis type 1\".\n\n2. **Assay Field**:\n   - The input term was \"anti-tag immunocytochemistry\".\n   - The schema's enum for assays includes \"immunocytochemistry\" but not \"anti-tag immunocytochemistry\".\n   - \"anti-tag\" is considered a specific detail that gets generalized to the broader term \"immunocytochemistry\".\n\n3. **TumorType Field**:\n   - The input term was \"sessile cutaneous neurofibroma\".\n   - \"Sessile\" describes a specific morphology not recognized in the schema. The closest match in the enum is \"Cutaneous Neurofibroma\".\n   - Hence, it is broadened to \"Cutaneous Neurofibroma\".\n\nThe resultant metadata strictly adheres to the controlled terminology in the schema."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2645,
              "outputTokens": 314,
              "totalTokens": 2959
            },
            "metrics": {
              "latencyMs": 4720
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2645,
          "output_tokens": 314,
          "total_tokens": 2959
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections Made:**\n1. **Diagnosis**: The input term \"neurofibromatosis, peripheral type\" has been broadened to \"Neurofibromatosis type 1,\" matching the controlled terminology exactly.\n2. **Assay**: The term \"wide bore MRI\" has been replaced with \"conventional MRI,\" which is the standardized equivalent in the Target Schema.\n3. **Tumor Type**: The value \"no clear diagnosis\" has been broadened to \"Unknown,\" adhering to the specified enum values.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2634,
            "outputTokens": 151,
            "totalTokens": 2785
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "2a8fc7ad-3745-4311-a2af-b52ec5b34752",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:47 GMT",
                "content-type": "application/json",
                "content-length": "808",
                "connection": "keep-alive",
                "x-amzn-requestid": "2a8fc7ad-3745-4311-a2af-b52ec5b34752"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Corrections Made:**\n1. **Diagnosis**: The input term \"neurofibromatosis, peripheral type\" has been broadened to \"Neurofibromatosis type 1,\" matching the controlled terminology exactly.\n2. **Assay**: The term \"wide bore MRI\" has been replaced with \"conventional MRI,\" which is the standardized equivalent in the Target Schema.\n3. **Tumor Type**: The value \"no clear diagnosis\" has been broadened to \"Unknown,\" adhering to the specified enum values."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2634,
              "outputTokens": 151,
              "totalTokens": 2785
            },
            "metrics": {
              "latencyMs": 2229
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2634,
          "output_tokens": 151,
          "total_tokens": 2785
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Vestibular Schwannoma\"\n}\n```\n\n**Explanation:**\n\n- **Diagnosis:** The term \"acoustic neurofibromatosis\" is not listed in the schema but refers to a condition related to NF2 (Neurofibromatosis Type 2), which is characterized by schwannomatosis, particularly vestibular schwannomas. The closest match in the schema is \"NF2-related schwannomatosis\".\n  \n- **Assay:** The term \"RNA-seq with ribosomal RNA depletion\" indicates a type of RNA sequencing. The closest match in the schema is simply \"RNA-seq\".\n\n- **Tumor Type:** \"Acoustic neuroma of left vestibular nerve\" specifically refers to a vestibular schwannoma, which is listed directly in the schema as \"Vestibular Schwannoma\".\n\nThe above corrections ensure compliance with the provided schema by using the exact controlled terminology values.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2642,
            "outputTokens": 235,
            "totalTokens": 2877
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "f080475f-bc50-47a5-a97b-d9832490c18b",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:50 GMT",
                "content-type": "application/json",
                "content-length": "1134",
                "connection": "keep-alive",
                "x-amzn-requestid": "f080475f-bc50-47a5-a97b-d9832490c18b"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Vestibular Schwannoma\"\n}\n```\n\n**Explanation:**\n\n- **Diagnosis:** The term \"acoustic neurofibromatosis\" is not listed in the schema but refers to a condition related to NF2 (Neurofibromatosis Type 2), which is characterized by schwannomatosis, particularly vestibular schwannomas. The closest match in the schema is \"NF2-related schwannomatosis\".\n  \n- **Assay:** The term \"RNA-seq with ribosomal RNA depletion\" indicates a type of RNA sequencing. The closest match in the schema is simply \"RNA-seq\".\n\n- **Tumor Type:** \"Acoustic neuroma of left vestibular nerve\" specifically refers to a vestibular schwannoma, which is listed directly in the schema as \"Vestibular Schwannoma\".\n\nThe above corrections ensure compliance with the provided schema by using the exact controlled terminology values."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2642,
              "outputTokens": 235,
              "totalTokens": 2877
            },
            "metrics": {
              "latencyMs": 3046
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2642,
          "output_tokens": 235,
          "total_tokens": 2877
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n1. **Diagnosis**:\n   - Original value: `\"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\"`\n   - Corrected value: `\"Neurofibromatosis type 1\"` (Matches the schema's enum exactly)\n\n2. **Assay**:\n   - Original value: `\"CellTiter-Glo\u00ae 3D Cell Viability Assay\"`\n   - Corrected value: `\"cell viability assay\"` (The closest match to the concept of cell viability in the schema)\n\n3. **Tumor Type**:\n   - Original value: `\"Epithelioid Malignant Peripheral Nerve Sheath Tumor\"`\n   - Corrected value: `\"Malignant Peripheral Nerve Sheath Tumor\"` (The closest match in the schema, as there is no exact match for the specific subtype \"Epithelioid\")\n\nThese changes ensure that all values conform to the provided controlled terminology and schema requirements.",
          "model_id": "us.amazon.nova-premier-v1:0",
          "usage": {
            "inputTokens": 2666,
            "outputTokens": 263,
            "totalTokens": 2929
          },
          "attempt": 1,
          "raw_response": {
            "ResponseMetadata": {
              "RequestId": "e6a5beac-acf1-4172-a70c-c9a64639832a",
              "HTTPStatusCode": 200,
              "HTTPHeaders": {
                "date": "Thu, 11 Dec 2025 05:37:54 GMT",
                "content-type": "application/json",
                "content-length": "1189",
                "connection": "keep-alive",
                "x-amzn-requestid": "e6a5beac-acf1-4172-a70c-c9a64639832a"
              },
              "RetryAttempts": 0
            },
            "output": {
              "message": {
                "role": "assistant",
                "content": [
                  {
                    "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```\n\n**Explanation:**\n1. **Diagnosis**:\n   - Original value: `\"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\"`\n   - Corrected value: `\"Neurofibromatosis type 1\"` (Matches the schema's enum exactly)\n\n2. **Assay**:\n   - Original value: `\"CellTiter-Glo\u00ae 3D Cell Viability Assay\"`\n   - Corrected value: `\"cell viability assay\"` (The closest match to the concept of cell viability in the schema)\n\n3. **Tumor Type**:\n   - Original value: `\"Epithelioid Malignant Peripheral Nerve Sheath Tumor\"`\n   - Corrected value: `\"Malignant Peripheral Nerve Sheath Tumor\"` (The closest match in the schema, as there is no exact match for the specific subtype \"Epithelioid\")\n\nThese changes ensure that all values conform to the provided controlled terminology and schema requirements."
                  }
                ]
              }
            },
            "stopReason": "end_turn",
            "usage": {
              "inputTokens": 2666,
              "outputTokens": 263,
              "totalTokens": 2929
            },
            "metrics": {
              "latencyMs": 3576
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2666,
          "output_tokens": 263,
          "total_tokens": 2929
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.8666666666666666,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 33.6910560131073,
    "token_usage": {
      "input_tokens": 26453,
      "output_tokens": 2197,
      "total_tokens": 28650
    }
  }
}